The distribution of Endometriosis Treatment Market Share is a dynamic battleground, recently reshaped by the successful launch and aggressive penetration of new drug classes. The largest market share is now being captured by companies that successfully commercialized the oral Gonadotropin-Releasing Hormone (GnRH) antagonist class. These agents, such as those launched by AbbVie (Orilissa)...